Clinical Trial Update: A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation

View source ↗

Summary

A trial update announcing completion of a study evaluating the effectiveness and safety of edoxaban in patients aged 80 or older with nonvalvular atrial fibrill…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Atrial Fibrillation | Status: COMPLETED